These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antibodies to HBV surface antigen in relation to interferon-λ3 in hemodialysis patients. Grzegorzewska AE; Świderska MK; Mostowska A; Warchoł W; Jagodziński PP Vaccine; 2016 Sep; 34(41):4866-4874. PubMed ID: 27595449 [TBL] [Abstract][Full Text] [Related]
3. Circulating interferon-λ3 and post-vaccination antibodies against the surface antigen of hepatitis B virus in hemodialysis patients exposed to hepatitis E virus. Grzegorzewska AE; Świderska MK; Winnicka H; Niepolski L; Bura M; Łagiedo-Żelazowska M; Jagodziński PP Cytokine; 2019 Nov; 123():154766. PubMed ID: 31279176 [TBL] [Abstract][Full Text] [Related]
4. Effect of interferon λ3 gene polymorphisms, rs8099917 and rs12979860, on response to hepatitis B virus vaccination and hepatitis B or C virus infections among hemodialysis patients. Grzegorzewska AE; Jodłowska E; Mostowska A; Jagodziński P Pol Arch Med Wewn; 2015; 125(12):894-902. PubMed ID: 26658164 [TBL] [Abstract][Full Text] [Related]
5. Polymorphism rs368234815 of interferon-λ4 gene and generation of antibodies to hepatitis B virus surface antigen in extracorporeal dialysis patients. Grzegorzewska AE; Świderska MK; Marcinkowski W; Mostowska A; Jagodziński PP Expert Rev Vaccines; 2020 Mar; 19(3):293-303. PubMed ID: 32228249 [No Abstract] [Full Text] [Related]
7. HBV and HCV infection in Japanese dental care workers. Nagao Y; Matsuoka H; Kawaguchi T; Ide T; Sata M Int J Mol Med; 2008 Jun; 21(6):791-9. PubMed ID: 18506374 [TBL] [Abstract][Full Text] [Related]
8. Association of the interleukin-12 polymorphic variants with the development of antibodies to surface antigen of hepatitis B virus in hemodialysis patients in response to vaccination or infection. Grzegorzewska AE; Wobszal PM; Sowińska A; Mostowska A; Jagodziński PP Mol Biol Rep; 2013 Dec; 40(12):6899-911. PubMed ID: 24158609 [TBL] [Abstract][Full Text] [Related]
9. Serum IFN-λ3 Levels Correlate with Serum Hepatitis C Virus RNA Levels in Symptomatic Patients with Acute Hepatitis C. Imoto S; Kim SR; Amano K; Iio E; Yoon S; Hirohata S; Yano Y; Ishikawa T; Katsushima S; Komeda T; Fukunaga T; Chung H; Kokuryu H; Horie Y; Hatae T; Fujinami A; Kim SK; Kudo M; Tanaka Y Dig Dis; 2017; 35(6):531-540. PubMed ID: 29040985 [TBL] [Abstract][Full Text] [Related]
10. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients]. Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725 [TBL] [Abstract][Full Text] [Related]
11. Response to hepatitis B virus vaccination in haemodialysis patients with and without hepatitis C infection. Sorkhi H; Roushan MR; Al Hashemi GH; Dooki MR; Bai S East Mediterr Health J; 2008; 14(4):798-803. PubMed ID: 19166162 [TBL] [Abstract][Full Text] [Related]
12. Factors affecting responsiveness to hepatitis B immunization in dialysis patients. Asan A; Demirhan H; Sorkun HÇ; Özkan S; Aydın M; Akın D; Tatar B; Çatak B; Şener A; Köse Ş Int Urol Nephrol; 2017 Oct; 49(10):1845-1850. PubMed ID: 28620716 [TBL] [Abstract][Full Text] [Related]
13. Genetic Polymorphisms within Interferon-λ Region and Interferon-λ3 in the Human Pathophysiology: Their Contribution to Outcome, Treatment, and Prevention of Infections with Hepatotropic Viruses. Grzegorzewska AE Curr Med Chem; 2019; 26(25):4832-4851. PubMed ID: 30027841 [TBL] [Abstract][Full Text] [Related]
14. Hepatitis B and C in the hemodialysis unit of Tocantins, Brazil: serological and molecular profiles. Souza KP; Luz JA; Teles SA; Carneiro MA; Oliveira LA; Gomes AS; Dias MA; Gomes SA; Yoshida CF; Martins RM Mem Inst Oswaldo Cruz; 2003 Jul; 98(5):599-603. PubMed ID: 13677340 [TBL] [Abstract][Full Text] [Related]
15. High hepatitis B virus surface antigen levels and favorable interleukin 28B genotype predict spontaneous hepatitis C virus clearance in uremic patients. Yu ML; Dai CY; Huang CF; Lee JJ; Yeh ML; Yeh SM; Kuo HT; Huang JF; Chang JM; Chen HC; Juo SH; Hwang SJ; Chuang WL; J Hepatol; 2014 Feb; 60(2):253-9. PubMed ID: 24096049 [TBL] [Abstract][Full Text] [Related]
16. Persistence of protection to hepatitis B vaccine and response to booster dose among children and adolescents in Dakahleya- Egypt. Salama II; Sami SM; Salama SI; Foud WA; Abdel Hamid AT; Said ZN Egypt J Immunol; 2014; 21(1):13-26. PubMed ID: 25204041 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice. Loggi E; Gitto S; Galli S; Minichiello M; Conti F; Grandini E; Scuteri A; Vitale G; Di Donato R; Cursaro C; Furlini G; Andreone P J Clin Virol; 2017 Aug; 93():66-70. PubMed ID: 28654775 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis B and C infection: is it a problem in Polish healthcare workers? Rybacki M; Piekarska A; Wiszniewska M; Walusiak-Skorupa J Int J Occup Med Environ Health; 2013 Jun; 26(3):430-9. PubMed ID: 23817869 [TBL] [Abstract][Full Text] [Related]
19. Detection of viral antigens in renal tissue of glomerulonephritis patients without serological evidence of hepatitis B virus and hepatitis C virus infection. Kong D; Wu D; Wang T; Li T; Xu S; Chen F; Jin X; Lou G Int J Infect Dis; 2013 Jul; 17(7):e535-8. PubMed ID: 23474175 [TBL] [Abstract][Full Text] [Related]
20. Different kinetics of HBV and HCV during haemodialysis and absence of seronegative viral hepatitis in patients with end-stage renal disease. Mederacke I; Meier M; Lüth JB; Schmidt-Gürtler H; Raupach R; Horn-Wichmann R; Wursthorn K; Potthoff A; Colucci G; Manns MP; Wedemeyer H; Tillmann HL Nephrol Dial Transplant; 2011 Aug; 26(8):2648-56. PubMed ID: 21273235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]